Justin Walsh
Stock Analyst at Jones Trading
(2.33)
# 2,045
Out of 4,479 analysts
23
Total ratings
45.83%
Success rate
-0.5%
Average return
Main Sectors:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Maintains: Buy | $15 → $22 | $10.49 | +109.72% | 2 | May 16, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Buy | $16 | $5.06 | +216.21% | 1 | May 10, 2024 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $99 | $78.50 | +26.11% | 5 | Apr 18, 2024 | |
| ACHV Achieve Life Sciences | Initiates: Buy | $20 | $4.59 | +335.73% | 1 | Apr 17, 2024 | |
| CTSO Cytosorbents | Reinstates: Buy | $4 | $0.82 | +386.74% | 2 | Sep 7, 2023 | |
| PRME Prime Medicine | Initiates: Buy | $20 | $5.28 | +278.79% | 1 | Sep 6, 2023 | |
| THTX Theratechnologies | Maintains: Buy | $24 → $12 | $1.41 | +751.06% | 1 | Jul 17, 2023 | |
| VOR Vor Biopharma | Initiates: Buy | $18 | $0.91 | +1,869.37% | 2 | May 16, 2023 | |
| TFFP TFF Pharmaceuticals | Initiates: Buy | $175 | $1.78 | +9,731.46% | 1 | Mar 22, 2023 | |
| MYNZ Mainz Biomed B.V. | Initiates: Buy | $11 | $0.34 | +3,144.84% | 1 | Feb 10, 2023 | |
| PSTV Plus Therapeutics | Initiates: Buy | $75 | $1.55 | +4,738.71% | 1 | Oct 7, 2022 | |
| HROW Harrow Health | Maintains: Buy | $17 → $20 | $20.85 | -4.08% | 1 | May 20, 2022 | |
| CRIS Curis | Maintains: Buy | $440 → $200 | $6.25 | +3,100.00% | 2 | Apr 5, 2022 | |
| CMPX Compass Therapeutics | Initiates: Buy | $10 | $0.88 | +1,036.36% | 1 | Jan 19, 2022 | |
| PRTG Portage Biotech | Initiates: Buy | n/a | $0.18 | - | 1 | Sep 2, 2021 |
Perspective Therapeutics
May 16, 2024
Maintains: Buy
Price Target: $15 → $22
Current: $10.49
Upside: +109.72%
TriSalus Life Sciences
May 10, 2024
Initiates: Buy
Price Target: $16
Current: $5.06
Upside: +216.21%
Lantheus Holdings
Apr 18, 2024
Maintains: Buy
Price Target: $95 → $99
Current: $78.50
Upside: +26.11%
Achieve Life Sciences
Apr 17, 2024
Initiates: Buy
Price Target: $20
Current: $4.59
Upside: +335.73%
Cytosorbents
Sep 7, 2023
Reinstates: Buy
Price Target: $4
Current: $0.82
Upside: +386.74%
Prime Medicine
Sep 6, 2023
Initiates: Buy
Price Target: $20
Current: $5.28
Upside: +278.79%
Theratechnologies
Jul 17, 2023
Maintains: Buy
Price Target: $24 → $12
Current: $1.41
Upside: +751.06%
Vor Biopharma
May 16, 2023
Initiates: Buy
Price Target: $18
Current: $0.91
Upside: +1,869.37%
TFF Pharmaceuticals
Mar 22, 2023
Initiates: Buy
Price Target: $175
Current: $1.78
Upside: +9,731.46%
Mainz Biomed B.V.
Feb 10, 2023
Initiates: Buy
Price Target: $11
Current: $0.34
Upside: +3,144.84%
Plus Therapeutics
Oct 7, 2022
Initiates: Buy
Price Target: $75
Current: $1.55
Upside: +4,738.71%
Harrow Health
May 20, 2022
Maintains: Buy
Price Target: $17 → $20
Current: $20.85
Upside: -4.08%
Curis
Apr 5, 2022
Maintains: Buy
Price Target: $440 → $200
Current: $6.25
Upside: +3,100.00%
Compass Therapeutics
Jan 19, 2022
Initiates: Buy
Price Target: $10
Current: $0.88
Upside: +1,036.36%
Portage Biotech
Sep 2, 2021
Initiates: Buy
Price Target: n/a
Current: $0.18
Upside: -